Background: The accuracy with which hemophilia A can be identified in claims databases is unknown.
Objective: Develop and validate an algorithm using predictive modeling supported by machine learning to identify patients with hemophilia A in an administrative claims database.
Methods: We first created a screening algorithm using medical and pharmacy claims to identify potential hemophilia A patients in the US HealthCore Integrated Research Database between January 1, 2006 and April 30, 2015. Medical records for a random sample of patients were reviewed to confirm case status. In this validation sample, we used lasso logistic regression with cross-validation to select covariates in claims data and develop a predictive model to estimate the probability of being a confirmed hemophilia A case.
Results: The screening algorithm identified 2,252 patients and we reviewed medical records for 400 of these patients. The screening algorithm had a positive predictive value (PPV) of 65%. The predictive model identified 18 predictors of being a hemophilia A case or noncase. The strongest predictors of case status included male sex, factor VIII therapy, office visits for hemophilia A, and hospitalizations for hemophilia A. The strongest predictors of noncase status included hospitalizations for reasons other than hemophilia A and factor VIIa therapy. A probability threshold of ≥0.6 resulted in a PPV of 94.7% (95% CI: 92.0-97.5) and sensitivity of 94.4% (95% CI: 91.5-97.2).
Conclusions: We developed and validated an algorithm to identify hemophilia A cases in an administrative claims database with high sensitivity and high PPV.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jval.2018.03.008 | DOI Listing |
Arch Phys Med Rehabil
December 2024
Department of Anesthesiology, Uniformed Services University, Bethesda, MD, USA. Electronic address:
Objective: To investigate inequities in time-to physical therapy for patients with low back pain.
Design: Retrospective observational study utilizing data from the Department of Defense and Veterans Health Administration clinical and administrative data repositories derived from medical records, claims, and enrollment data.
Setting: Military Health System, Veterans Health System, and civilian healthcare facilities.
J Manag Care Spec Pharm
January 2025
University of Mississippi School of Pharmacy, University.
Background: The Centers for Medicare and Medicaid Services (CMS) Star Ratings program incentivizes health plans in Medicare to improve performance on a variety of quality measures such as adherence to renin-angiotensin system antagonists (RASAs). Adherence to RASA medications, defined as having a proportion of days covered (PDC) of at least 80%, has been improving for several years, suggesting that further investigation is needed to assess the appropriateness of the current 80% PDC threshold for medication adherence as an indicator of quality. The 80% PDC threshold has been found to be associated with improved health care resource utilization outcomes; however, little evidence exists to show that this threshold is optimal.
View Article and Find Full Text PDFJACC Adv
November 2024
AstraZeneca, Wilmington, Delaware, USA.
J Urol
December 2024
Department of Urology, School of Medicine, Stanford University, Stanford, CA 94305, United States.
Purpose: To characterize trends in vasectomy utilization, delivery, and failure in a large administrative database.
Materials And Methods: We utilized the Merative MarketScan® (2007-2021) Commercial Database to identify vasectomized men. Vasectomy failure (VF) was defined as documented pregnancy ≥6 months post-procedure.
Med Care
December 2024
Department of Health Care Policy, Harvard Medical School, Boston, MA.
Objective: To quantify quality of care following an admission to a nursing home with low or high antipsychotic drug use.
Background: Misuse of antipsychotics in U.S.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!